Skip to content

Careers
Blog
Contact Us
English
- French

What’s Next
Our Services
Our Expertise
About Us
- About Us
- Our Sites
  - Laval
  - Gosselies
  - Marburg
  - Porton Down
- Our Scientists
News & Events
- News
- Events
Resources

2019

News

NEOMED-LABS and Public Health England Announce a Strategic Agreement

27 Jun 2019

News

NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune

6 Jun 2019

About Nexelis, a Q² Solutions Company

With unrivaled expertise in immunology, 4 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lead selection to the late clinical stage, Nexelis, a Q² Solutions Company, is a leading provider of assay development and advanced laboratory testing services in the infectious, metabolic and oncologic fields. Our versatile team of scientists, working with state of the art technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 350 new molecular entities, including blockbuster vaccines and biologics, anti-viral drugs, immunotherapy, gene and cell therapy products.

A Q² Solutions Company

Contact Us

Q² Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

Contact Us

Careers
Quality Assurance
Information Technology

Follow Us LinkedIn Twitter YouTube

© 2024 Nexelis, a Q² Solutions Company. All Rights Reserved.

Privacy
Terms of Use

What’s Next
Our Services
Our Expertise
About Us
- About Us
- Our Sites
  - Laval
  - Gosselies
  - Marburg
  - Porton Down
- Our Scientists
News & Events
- News
- Events
Resources

Careers
Blog
Contact Us
English
- French